{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:15:29Z","timestamp":1791616529715,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jbc.2024.108070","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T02:26:34Z","timestamp":1733797594000},"page":"108070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Downregulation of the splicing regulator NSRP1 confers resistance to CDK4\/6 inhibitors via activation of interferon signaling in breast cancer"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9926-852X","authenticated-orcid":false,"given":"Shiyi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caili","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoqiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.108070_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2024.108070_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s13402-022-00765-7","article-title":"The Breast Cancer Single-Cell Atlas: defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, treatment options","volume":"46","author":"Dave","year":"2023","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.jbc.2024.108070_bib3","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-23-0015","article-title":"LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity","volume":"83","author":"Yu","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-023-00523-4","article-title":"An emerging generation of endocrine therapies in breast cancer: a clinical perspective","volume":"9","author":"Patel","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jbc.2024.108070_bib5","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","article-title":"Palbociclib and letrozole in advanced breast cancer","volume":"375","author":"Finn","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2024.108070_bib6","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","article-title":"Monarch 3: abemaciclib as initial therapy for advanced breast cancer","volume":"35","author":"Goetz","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jbc.2024.108070_bib7","article-title":"Co-targeting RANK pathway treats and prevents acquired resistance to CDK4\/6 inhibitors in luminal breast cancer","volume":"4","author":"Gomes","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jbc.2024.108070_bib8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1158\/1078-0432.CCR-23-2975","article-title":"Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor-positive breast cancer","volume":"30","author":"Guarducci","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ccell.2018.11.006","article-title":"Loss of the FAT1 tumor suppressor promotes resistance to CDK4\/6 inhibitors via the Hippo pathway","volume":"34","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2024.108070_bib10","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-22-2206","article-title":"CCNE1 and PLK1 mediate resistance to palbociclib in HR+\/HER2- metastatic breast cancer","volume":"29","author":"Guerrero-Zotano","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib11","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1158\/1078-0432.CCR-19-4191","article-title":"Activation of the IFN signaling pathway is associated with resistance to CDK4\/6 inhibitors and immune checkpoint activation in ER-positive breast cancer","volume":"27","author":"De Angelis","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","article-title":"Roles and mechanisms of alternative splicing in cancer - implications for care","volume":"17","author":"Bonnal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2024.108070_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","article-title":"RNA splicing dysregulation and the hallmarks of cancer","volume":"23","author":"Bradley","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2024.108070_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cas.14240","article-title":"RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8","volume":"111","author":"Iino","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2024.108070_bib15","article-title":"Prediction of RNA-binding protein and alternative splicing event associations during epithelial-mesenchymal transition based on inductive matrix completion","volume":"22","author":"Qiu","year":"2021","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.jbc.2024.108070_bib16","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1073\/pnas.0603339103","article-title":"A\u00a0variant of estrogen receptor-alpha, hER-alpha36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108070_bib17","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1038\/s41467-022-34702-x","article-title":"Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108070_bib18","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41467-024-46495-2","article-title":"PRMT5 is an actionable therapeutic target in CDK4\/6 inhibitor-resistant ER+\/RB-deficient breast cancer","volume":"15","author":"Lin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108070_bib19","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1093\/nar\/gkq1267","article-title":"NSrp70 is a novel nuclear speckle-related protein that modulates alternative pre-mRNA splicing in\u00a0vivo","volume":"39","author":"Kim","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108070_bib20","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1093\/nar\/gkab389","article-title":"NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108070_bib21","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/s41388-022-02349-z","article-title":"NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb\/TbetaR1\/EMT axis","volume":"41","author":"Zhao","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2024.108070_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2024.108070_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2024.108070_bib24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance Program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.108070_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.stem.2023.05.007","article-title":"IFNgamma-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy","volume":"30","author":"Beziaud","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbc.2024.108070_bib26","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","article-title":"Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation","volume":"81","author":"Yu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.108070_bib27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jbc.2024.108070_bib28","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/1078-0432.CCR-16-3206","article-title":"NeoPalAna: neoadjuvant palbociclib, a cyclin-dependent kinase 4\/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor-positive breast cancer","volume":"23","author":"Ma","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-019-1069-3","article-title":"SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination","volume":"38","author":"Li","year":"2019","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910638","article-title":"Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer","volume":"11","author":"Ye","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbc.2024.108070_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112014","article-title":"Inhibitors of the interferon response enhance virus replication in\u00a0vitro","volume":"9","author":"Stewart","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2024.108070_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-021-04032-9","article-title":"Chromatin remodeler ARID1A binds IRF3 to selectively induce antiviral interferon production in macrophages","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2024.108070_bib33","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3389\/fimmu.2017.00972","article-title":"H-ras exerts opposing effects on type I interferon responses depending on its activation status","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2024.108070_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41435-020-0095-7","article-title":"Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils","volume":"21","author":"Heeb","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.jbc.2024.108070_bib35","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41467-019-10970-y","article-title":"A\u00a0molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription","volume":"10","author":"Platanitis","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108070_bib36","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.108070_bib37","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(19871115)60:10<2419::AID-CNCR2820601011>3.0.CO;2-S","article-title":"Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells","volume":"60","author":"Sica","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.jbc.2024.108070_bib38","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1158\/1078-0432.CCR-11-3225","article-title":"Molecular pathways: interferon\/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth","volume":"18","author":"Khodarev","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib39","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1158\/1078-0432.CCR-17-2551","article-title":"Interferon-stimulated genes are involved in cross-resistance to radiotherapy in tamoxifen-resistant breast cancer","volume":"24","author":"Post","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.108070_bib40","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1074\/jbc.M115.689414","article-title":"Nuclear speckle-related protein 70 binds to serine\/arginine-rich splicing factors 1 and 2 via an arginine\/serine-like region and counteracts their alternative splicing activity","volume":"291","author":"Kim","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.108070_bib41","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1038\/s41388-021-01747-z","article-title":"NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2024.108070_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00018-016-2435-3","article-title":"A\u00a0novel anti-viral role for STAT3 in IFN-alpha signalling responses","volume":"74","author":"Mahony","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jbc.2024.108070_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/cr.2014.71","article-title":"An epigenomic approach to therapy for tamoxifen-resistant breast cancer","volume":"24","author":"Feng","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2024.108070_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41388-022-02578-2","article-title":"Monitoring the 5\u2032UTR landscape reveals isoform switches to drive translational efficiencies in cancer","volume":"42","author":"Weber","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2024.108070_bib45","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.108070_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2024.108070_bib47","doi-asserted-by":"crossref","first-page":"D307","DOI":"10.1093\/nar\/gkz823","article-title":"EuRBPDB: a comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs)","volume":"48","author":"Liao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108070_bib48","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gyorffy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jbc.2024.108070_bib49","doi-asserted-by":"crossref","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","article-title":"TCGASpliceSeq a compendium of alternative mRNA splicing in cancer","volume":"44","author":"Ryan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108070_bib50","doi-asserted-by":"crossref","first-page":"D248","DOI":"10.1093\/nar\/gkac1094","article-title":"Ribo-uORF: a comprehensive data resource of upstream open reading frames (uORFs) based on ribosome profiling","volume":"51","author":"Liu","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2024.108070_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response","volume":"22","author":"Hu","year":"2021","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.jbc.2024.108070_bib52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2024.108070_bib53","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824025729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:16:37Z","timestamp":1737994597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824025729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0021925824025729"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108070","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of the splicing regulator NSRP1 confers resistance to CDK4\/6 inhibitors via activation of interferon signaling in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.108070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"108070"}}